ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
ARS Pharmaceuticals Inc

ARS Pharmaceuticals Inc (SPRY)

12.57
0.39
(3.20%)
終了 1月21日 6:00AM
12.57
0.01
(0.08%)
取引時間後: 9:25AM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
12.57
買値
12.06
売値
18.00
出来高
1,679,780
12.19 日の範囲 12.9899
5.8054 52 週間の範囲 18.51
時価総額
前日終値
12.18
始値
12.26
最終取引時間
財務取引量
US$ 21,143,251
VWAP
12.5869
平均取引量 (3 か月)
1,259,977
発行済株式数
97,185,475
配当利回り
-
PER
-22.45
1 株当たり利益 (EPS)
-0.56
歳入
30k
純利益
-54.37M

ARS Pharmaceuticals Inc について

ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for pa... ARS Pharmaceuticals Inc is a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis. The company is developing neffy, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
ARS Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker SPRY. The last closing price for ARS Pharmaceuticals was US$12.18. Over the last year, ARS Pharmaceuticals shares have traded in a share price range of US$ 5.8054 to US$ 18.51.

ARS Pharmaceuticals currently has 97,185,475 shares in issue. The market capitalisation of ARS Pharmaceuticals is US$1.18 billion. ARS Pharmaceuticals has a price to earnings ratio (PE ratio) of -22.45.

SPRY 最新ニュース

ARS Pharmaceuticals Announces Preliminary Fourth Quarter 2024 Financial Results and 2025 Objectives for neffy® (epinephrine nasal spray)

Preliminary fourth quarter neffy® net product revenue of approximately $6.5 million Preliminary cash, cash equivalents and short-term investments of $314.0 million at year-end 2024 to support an...

ARS Pharmaceuticals Files for Approval of neffy® in Canada and the United Kingdom on Behalf of Licensing Partner ALK-Abelló A/S

Canada and United Kingdom represent two of the largest markets within the ALK portfolio with plans to expand filings of neffy (epinephrine nasal spray) 2 mg in other key global regions SAN DIEGO...

ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies

Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19...

ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 18, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
11.412.53357206811.1712.5710.7156258411.62974077CS
41.3912.432915921311.1812.5710.2148227711.21157831CS
12-2.91-18.798449612415.4818.5110.2125997713.12585229CS
261.4913.447653429611.0818.518.9055116606213.18434491CS
526.65112.3310810815.9218.515.805488156911.75150912CS
1567.29138.0681818185.2818.512.558466178.79858066CS
2607.29138.0681818185.2818.512.558466178.79858066CS

SPRY - Frequently Asked Questions (FAQ)

What is the current ARS Pharmaceuticals share price?
The current share price of ARS Pharmaceuticals is US$ 12.57
How many ARS Pharmaceuticals shares are in issue?
ARS Pharmaceuticals has 97,185,475 shares in issue
What is the market cap of ARS Pharmaceuticals?
The market capitalisation of ARS Pharmaceuticals is USD 1.18B
What is the 1 year trading range for ARS Pharmaceuticals share price?
ARS Pharmaceuticals has traded in the range of US$ 5.8054 to US$ 18.51 during the past year
What is the PE ratio of ARS Pharmaceuticals?
The price to earnings ratio of ARS Pharmaceuticals is -22.45
What is the cash to sales ratio of ARS Pharmaceuticals?
The cash to sales ratio of ARS Pharmaceuticals is 41.87k
What is the reporting currency for ARS Pharmaceuticals?
ARS Pharmaceuticals reports financial results in USD
What is the latest annual turnover for ARS Pharmaceuticals?
The latest annual turnover of ARS Pharmaceuticals is USD 30k
What is the latest annual profit for ARS Pharmaceuticals?
The latest annual profit of ARS Pharmaceuticals is USD -54.37M
What is the registered address of ARS Pharmaceuticals?
The registered address for ARS Pharmaceuticals is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
What is the ARS Pharmaceuticals website address?
The website address for ARS Pharmaceuticals is ars-pharma.com
Which industry sector does ARS Pharmaceuticals operate in?
ARS Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

SPRY Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock